Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the ...
These essential public speaking truths will help you engage your audience, increase your confidence, and deliver ...
Nvidia CEO Jensen Huang on Tuesday kicked off the AI chipmaker's GTC 2025 conference with a presentation highlighting the ...
Every major presentation tool has an AI feature now. The results are generic decks that technically contain slides but ...
Oxylabs explores how fresh web data infrastructure helps AI systems reduce hallucinations and deliver accurate real-world ...
Qualcomm QCOM-Q said it expects to generate US$15-billion in sales from its data centre business by 2029 as it moves beyond ...
AP-101 is an investigational human-derived antibody that selectively targets the misfolded, toxic form of superoxide dismutase 1 (SOD1) to disrupt the progressive spread of ALS. The goal of this ...
A good software architecture ensures that an AI system does not depend on the performance of a specific model.
At the recent Google Marketing Live event, the search engine described how their data was showing that AI-powered search is ...
Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and ...
STAMFORD, Conn., June 05, 2026 (GLOBE NEWSWIRE) -- Oban BioPharma today announced that preclinical data for OBT-676, a lead small-molecule candidate for the treatment of obesity and type 2 diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results